TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 55,323 | 53,690 | 46,544 |
Financial expenses | 36 | 12 | 31 |
Earnings before taxes | 3,833 | 7,281 | 7,056 |
EBITDA | 7,282 | 10,202 | 9,489 |
Total assets | 47,900 | 44,141 | 33,385 |
Current assets | 37,912 | 30,744 | 27,200 |
Current liabilities | 25,325 | 23,265 | 18,659 |
Equity capital | 20,896 | 19,259 | 13,801 |
- share capital | 36 | 39 | 40 |
Employees (average) | 51 | 39 | 27 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 43.6% | 43.6% | 41.3% |
Turnover per employee | 1,085 | 1,377 | 1,724 |
Profit as a percentage of turnover | 6.9% | 13.6% | 15.2% |
Return on assets (ROA) | 8.1% | 16.5% | 21.2% |
Current ratio | 149.7% | 132.1% | 145.8% |
Return on equity (ROE) | 18.3% | 37.8% | 51.1% |
Change turnover | 5,982 | 8,027 | 14,616 |
Change turnover % | 12% | 18% | 46% |
Chg. No. of employees | 12 | 12 | 5 |
Chg. No. of employees % | 31% | 44% | 23% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.